Reporting Season

After a 200% rise in a year, does Pro Medicus have another gear?

We sat down with Pro Medicus CEO, Dr Sam Hupert on results day to discuss the past six months and the all-important outlook.
Chris Conway
Livewire Markets
Reporting Season

FNArena reporting season monitor: February 2025 - Week 2 (47 stocks covered)

Read on to find the ratings, consensus price targets, and FNArena insights on each stock covered.
Rudi Filapek-Vandyck
FNArena
Reporting Season

3 ASX growth stocks to watch as earnings hit a turning point

Earnings may have bottomed out and there's hope in the air this reporting season, according to FNArena's Rudi Filapek-Vandyck
COH
+8
Sara Allen
Livewire Markets
Reporting Season

CBA is expensive. But it continues to deliver on earnings and dividends

CBA's first-half result continues to showcase the same narrative – consistent earnings and dividends at a very, very expensive price tag.
Kerry Sun
Livewire Markets
Reporting Season

Morgans' equity strategy insights and 11 key calls for February 2025

Our focus in February is on companies and sectors that continue to see margin resilience and positive earnings trends.
Andrew Tang
Morgans Financial
Reporting Season

Why are investors buying Nick Scali?

Despite the fact it overshot its own guidance, Nick Scali's result may be the clearest sign of a consumer slowdown yet.
NCK
Hans Lee
Livewire Markets
Reporting Season

FNArena reporting season monitor: February 2025 - Week 1 (10 stocks covered)

Read on to find the ratings, consensus price targets, and FNArena insights on each stock covered.
AMC
BPT
BWP
+7
Rudi Filapek-Vandyck
FNArena
Reporting Season

Download Livewire's February Reporting Season Guide, with analysis of 10 ASX companies

We've put together the quintessential reporting season guide as we head into Feburary reporting season.
Chris Conway
Livewire Markets
Reporting Season

CEO of ASX's newest uranium producer Boss Energy says: "It's time to repay the faith"

Boss Energy is profitable, sitting on strategic stockpiles of uranium and cash, and is debt-free – a most envious position among ASX miners.
BOE
Carl Capolingua
Livewire Markets
Reporting Season

ResMed's latest earnings are "super impressive", says this fund manager

Could this Australian-American healthcare stalwart hit $60/share?
RMD
Hans Lee
Livewire Markets
Reporting Season

The ASX-listed 10-bagger with its sights on global domination

Livewire sat down with Life360's CEO and co-founder Chris Hulls for an exclusive conversation on the company's outlook.
360
Ally Selby
Livewire Markets
Reporting Season

A is for ambition: Apple and Amazon bet big on the future

These tech giants are laying down markers for how they see the next stage of tech evolution unfolding.
+1
Trent Masters
Alphinity Investment Management
Reporting Season

Are we at 'peak earnings' for these stocks?

The question of falling interest rates and a potential flow onto margins has been in focus this US earnings season.
+1
Hans Lee
Livewire Markets
Reporting Season

The US$115 billion question: Will Meta and Microsoft's huge spending on AI be worth it?

Many of the Magnificent Seven reported their earnings this week. In this wire, we cover the one thing two key results have in common.
+1
Hans Lee
Livewire Markets
Reporting Season

FNArena reporting season monitor: August 2024 – Week Five (384 stocks covered)

Read on to find the ratings, consensus price targets, and FNArena insights on each stock covered.
+31
Rudi Filapek-Vandyck
FNArena
Reporting Season

FNArena reporting season monitor: August 2024 – Week Four (303 stocks covered)

Read on to find the ratings, consensus price targets, and FNArena insights on each stock covered.
ALX
+21
Rudi Filapek-Vandyck
FNArena
Reporting Season

This stock has fallen 43% in 12 months. But is it really as bad as it seems?

Livewire sits down with Katana Asset Management's Romano Sala Tenna to find out.
Ally Selby
Livewire Markets
Reporting Season

You don't get more blue chip than Wesfarmers, but does it deserve a spot in your portfolio?

Wesfarmers appears to have delivered another strong performance in FY24. We asked an expert whether the blue chip is a buy, hold, or sell.
JBH
WES
Carl Capolingua
Livewire Markets
Reporting Season

NVIDIA made US$30 billion in revenue last quarter - but this analyst isn't buying

The optimists have been left disappointed by a revenue forecast that doesn't stack up to its track record.
WGB
+3
Hans Lee
Livewire Markets
Reporting Season

Woolworths and Coles: Strong FY24 results with "stable growth at cheap valuations"

Australia's supermarket duopoly topped FY24 earnings expectations, and this could be their time to shine.
COL
JBH
+2
Kerry Sun
Livewire Markets
Reporting Season

Is Fortescue's 70% dividend payout sustainable?

Fortescue's results were largely in line with expectations but investors will be watching iron ore projections and green project expenditure
Sara Allen
Livewire Markets
Reporting Season

Why Woodside believes its dividend bonanza can continue

Plus, CEO Meg O'Neill shares what the market is getting wrong about the company's two latest acquisitions.
Ally Selby
Livewire Markets
Reporting Season

Why BHP is still bullish on iron ore and betting $7.4bn on copper

BHP’s CFO Vandita Pant believes there’s still plenty of mileage in iron ore demand for the Big Australian, while boosting alternatives.
BHP
Sara Allen
Livewire Markets
Reporting Season

Despite lower iron ore prices, BHP will return $11 billion to shareholders in FY24

The Big Australian may have cut its dividend but its total payout still ranks first in class.
BHP
GMG
Hans Lee
Livewire Markets
Reporting Season

FNArena reporting season monitor: August 2024 – Week Three (169 stocks covered)

Read on to find the ratings, consensus price targets, and FNArena insights on each stock covered.
A1M
ACF
+33
Rudi Filapek-Vandyck
FNArena
51-75 of 345